| 29th week of 2016 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20160206566 | DELIVERY OF CAS9 VIA ARRDC1-MEDIATED MICROVESICLES (ARMMS) | 2016-07-21 |
| 20160206567 | ANTIFUNGAL TOPICAL COMPOSITION AND METHODS OF TREATMENT | 2016-07-21 |
| 20160206568 | ADHESIVE SHEET FOR APPLICATION TO THE SKIN, AND PERCUTANEOUS ABSORPTION PREPARATION USING SAME | 2016-07-21 |
| 20160206569 | Cataplasm and Method for Producing the Same | 2016-07-21 |
| 20160206570 | CARDIOPROTECTANT TO REDUCE DAMAGE FROM HEART ATTACK | 2016-07-21 |
| 20160206571 | ACTIVE MIXTURES | 2016-07-21 |
| 20160206572 | COMPOSITIONS COMPRISING A DENDRIMER-RESVERATROL COMPLEX AND METHODS FOR MAKING AND USING THE SAME | 2016-07-21 |
| 20160206573 | Anti-Acne Formulation | 2016-07-21 |
| 20160206574 | Paediatric Compositions For Treating Multiple Sclerosis | 2016-07-21 |
| 20160206575 | Inhibition of Biofilm Organisms | 2016-07-21 |
| 20160206576 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) IN THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS | 2016-07-21 |
| 20160206577 | NOVEL DRUG FORMULATION | 2016-07-21 |
| 20160206578 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use | 2016-07-21 |
| 20160206579 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION | 2016-07-21 |
| 20160206580 | MULTIVESICULAR LIPOSOME FORMULATIONS OF TRANEXAMIC ACID | 2016-07-21 |
| 20160206581 | TREATMENT AND PREVENTION OF AUTISM AND AUTISM SPECTRUM DISORDERS | 2016-07-21 |
| 20160206582 | ENHANCER OF SURVIVAL OF TRANSPLANTED ORGAN | 2016-07-21 |
| 20160206583 | AMINO ACID TREATMENT OF SEIZURES | 2016-07-21 |
| 20160206584 | LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE | 2016-07-21 |
| 20160206585 | A COMPOSITION COMPRISING A LIPID COMPOUND, A TRIGLYCERIDE, AND A SURFACTANT, AND METHODS OF USING THE SAME | 2016-07-21 |
| 20160206586 | PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE | 2016-07-21 |
| 20160206587 | PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE | 2016-07-21 |
| 20160206588 | STABILIZED FORMULATIONS OF FATTY ACIDS | 2016-07-21 |
| 20160206589 | PHARMACEUTICAL USE OF 3-BENZYLSULFONYLPROPIONITRILE | 2016-07-21 |
| 20160206590 | BPO WASH EMULSION COMPOSITION | 2016-07-21 |
| 20160206591 | TREATMENTS FOR FIBROTIC DISEASES | 2016-07-21 |
| 20160206592 | METHOD FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS BY INHIBITION OF CXCR4/CXCL12 SIGNALING | 2016-07-21 |
| 20160206593 | PHARMACEUTICAL FOR PROPHYLAXIS OR TREATMENT OF HYPERTENSION | 2016-07-21 |
| 20160206594 | Pro-Neurogenic Compounds | 2016-07-21 |
| 20160206595 | INDOLE-3-ALDEHYDE FOR TREATING DYSREACTIVE IMMUNE DISORDERS | 2016-07-21 |
| 20160206596 | Anti-depression Compounds | 2016-07-21 |
| 20160206597 | New Use | 2016-07-21 |
| 20160206598 | THERAPEUTIC AGENT FOR DYSLIPIDEMIA | 2016-07-21 |
| 20160206599 | OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIOR SEGMENT OF THE EYE | 2016-07-21 |
| 20160206600 | ADHESIVE COMPOSITION FOR CARRYING THERAPEUTIC AGENTS AS DELIVERY VEHICLE ON COATING APPLIED TO VASCULAR GRAFTS | 2016-07-21 |
| 20160206601 | Methods and Compositions for Re-activating Epstein-Barr Virus and Screening Compounds Therefor | 2016-07-21 |
| 20160206602 | COMPOSITIONS AND METHODS FOR ENHANCING BRAIN FUNCTION | 2016-07-21 |
| 20160206603 | COMPOSITION COMPRISING TORASEMIDE AND BACLOFEN FOR TREATING NEUROLOGICAL DISORDERS | 2016-07-21 |
| 20160206604 | FORMULATIONS COMPRISING WETTING AGENTS AND COMPOUNDS FOR THE MODULATION OF HEMOGLOBIN (S) | 2016-07-21 |
| 20160206605 | COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR | 2016-07-21 |
| 20160206606 | TOPICAL COMPOSITIONS COMPRISING A THIAZOLIDINEDIONE | 2016-07-21 |
| 20160206607 | Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | 2016-07-21 |
| 20160206608 | CRIZOTINIB FOR USE IN THE TREATMENT OF CANCER | 2016-07-21 |
| 20160206609 | NEUROPROTECTIVE POLYPHENOL ANALOGS | 2016-07-21 |
| 20160206610 | METHODS FOR TREATING AND/OR PREVENTING EMESIS AND/OR NAUSEA INCLUDING ACUTE AND/OR DELAYED NAUSEA AND/OR ACUTE EMESIS AND/OR DELAYED EMESIS | 2016-07-21 |
| 20160206611 | APOPTOSIS-INDUCED AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2016-07-21 |
| 20160206612 | ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE | 2016-07-21 |
| 20160206613 | INHIBITORS OF ACTIVIN-LIKE RECEPTOR KINASES | 2016-07-21 |
| 20160206614 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | 2016-07-21 |
| 20160206615 | NANOPARTICLE DRUG DELIVERY SYSTEM AND METHOD OF TREATING CANCER AND NEUROTRAUMA | 2016-07-21 |
| 20160206616 | DIHYDROPYRIMIDINE COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS | 2016-07-21 |
| 20160206617 | COMPOSITIONS AND THERAPEUTIC METHODS FOR ACCELERATED PLAQUE REGRESSION | 2016-07-21 |
| 20160206618 | COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL | 2016-07-21 |
| 20160206619 | INHIBITION OF ADAPTOR ASSOCIATED KINASE 1 FOR THE TREATMENT OF PAIN | 2016-07-21 |
| 20160206620 | PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-RELATED DISEASES | 2016-07-21 |
| 20160206621 | FUSED TRICYCLIC COMPOUNDS AS RAF KINASE INHIBITORS | 2016-07-21 |
| 20160206622 | EMULSION FORMULATIONS OF APREPITANT | 2016-07-21 |
| 20160206623 | Composition For Prevention of Vasoactivity in the Treatment of Blood Loss and Anemia | 2016-07-21 |
| 20160206624 | MEDICAMENT FOR TREATMENT OF ALZHEIMER'S DISEASE | 2016-07-21 |
| 20160206625 | MOLYBDENUM COMPOUNDS FOR USE IN THE TREATMENT OF CYANIDE POISONING | 2016-07-21 |
| 20160206626 | TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH | 2016-07-21 |
| 20160206627 | CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS | 2016-07-21 |
| 20160206628 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | 2016-07-21 |
| 20160206629 | TOPICAL COMPOSITION COMPRISING A FILM-FORMING POLYMER FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN | 2016-07-21 |
| 20160206631 | OXYSTEROLS THAT ACTIVATE LIVER X RECEPTOR SIGNALING AND INHIBIT HEDGEHOG SIGNALING | 2016-07-21 |
| 20160206632 | MULTIFUNCTIONAL TOPICAL FORMULATION FOR THE TREATMENT OF ACNE VULGARIS AND OTHER SKIN CONDITIONS | 2016-07-21 |
| 20160206633 | dhS1P AND USE OF SAME AS AN ANTICANCER THERAPEUTIC AND IMMUNOMODULATOR | 2016-07-21 |
| 20160206634 | OMEGA-3 PHOSPHOLIPID SUPPLEMENTS FOR IMPROVED BRAIN MATURITY | 2016-07-21 |
| 20160206635 | Butyrylcholinesterase Inhibitors | 2016-07-21 |
| 20160206636 | DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE | 2016-07-21 |
| 20160206637 | Effects of Alpha-Glycerophosphocholine Versus Caffeine in Measures of Cognitive, Psychological and Physiological Functions | 2016-07-21 |
| 20160206638 | BORON-CONTAINING SMALL MOLECULES | 2016-07-21 |
| 20160206639 | Films and Drug Delivery Systems Made Therefrom | 2016-07-21 |
| 20160206640 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING NEUROPSYCHIATRIC DISEASE, CONTAINING FLAVONE-6-C-GLUCOSE DERIVATIVES AS ACTIVE INGREDIENTS | 2016-07-21 |
| 20160206641 | RAPIDLY-DISSOLVING THIN FILM FORMULATION OF WATER SOLUBLE DIGITALIS GLYCOSIDE FOR THE TREATMENT OF CONGESTIVE HEART DISEASE | 2016-07-21 |
| 20160206642 | CLOCK GENE EXPRESSION LEVEL REGULATOR | 2016-07-21 |
| 20160206643 | ANTI-OBESITY COMPOSITION | 2016-07-21 |
| 20160206644 | Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof | 2016-07-21 |
| 20160206645 | COMBINATION THERAPIES FOR TREATMENT OF HCV | 2016-07-21 |
| 20160206646 | Bruton's Tyrosine Kinase as Anti-Cancer Drug Target | 2016-07-21 |
| 20160206647 | NANOCOMPLEXES FOR CO-DELIVERING A DRUG AND SIRNA AND USES THEREOF | 2016-07-21 |
| 20160206648 | DIETARY FIBER CONTAINING MATERIALS COMPRISING LOW MOLECULAR WEIGHT GLUCAN | 2016-07-21 |
| 20160206649 | Compositions and Methods For Treating Joints | 2016-07-21 |
| 20160206650 | Methods and Compositions for Bowel Cleansing Before a Medical Procedure | 2016-07-21 |
| 20160206651 | COMPOSITIONS AND METHODS OF TREATING MICROBES | 2016-07-21 |
| 20160206652 | CERIUM OXIDE NANOPARTICLES FOR THE TREATMENT AND PREVENTION OF STROKE AND CARDIOVASCULAR DISEASE | 2016-07-21 |
| 20160206653 | METAL-GLYCOPROTEIN COMPLEXES AND THEIR USE AS CHEMOTHERAPEUTIC COMPOUNDS | 2016-07-21 |
| 20160206654 | METHODS AND FEED SUPPLEMENTS FOR LIVESTOCK | 2016-07-21 |
| 20160206655 | ACELLULAR PRO-INFLAMMATORY COMPOSITIONS, PROCESS FOR MAKING SAME AND METHODS OF USING SAME | 2016-07-21 |
| 20160206656 | METHODS AND COMPOSITIONS FOR DOSING IN ADOPTIVE CELL THERAPY | 2016-07-21 |
| 20160206657 | COMPOSITIONS AND MINIMALLY INVASIVE METHODS FOR TREATING INCOMPLETE TISSUE REPAIR | 2016-07-21 |
| 20160206658 | NUTRITION FOR PREVENTION OF INFECTIONS | 2016-07-21 |
| 20160206659 | ISOLATED RENAL CELLS AND USES THEREOF | 2016-07-21 |
| 20160206660 | COMPOSITION OF STEM CELLS HAVING HIGHLY EXPRESSED FAS LIGAND | 2016-07-21 |
| 20160206661 | METHODS OF USING ADIPOSE TISSUE-DERIVED CELLS IN THE MODULATION OF PAIN AND/OR FIBROSIS | 2016-07-21 |
| 20160206662 | CELL FUSION PROMOTER AND UTILIZATION OF THE SAME | 2016-07-21 |
| 20160206663 | Compositions and Methods for Producing Reconstituted Skin | 2016-07-21 |
| 20160206664 | METHOD FOR PRODUCING ADULT LIVER PROGENITOR CELLS | 2016-07-21 |
| 20160206665 | ENCAPSULATED CELLS FOR HORMONE REPLACEMENT THERAPY | 2016-07-21 |
| 20160206666 | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier | 2016-07-21 |
